Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Molecular Medicine (Cambridge, Mass.)|December 21, 2011
The receptor that tames the innate immune responseMichael Brines, Anthony CeramiMolecular Biotechnology|October 19, 2005
Tumor necrosis factor as a pharmacological targetPietro Ghezzi, Anthony CeramiNature Reviews. Neuroscience|June 2, 2005
Emerging biological roles for erythropoietin in the nervous systemMichael Brines, Anthony CeramiMethods in Molecular Medicine|April 6, 2004
Tumor necrosis factor as a pharmacological targetPietro Ghezzi, Anthony CeramiMethods in Molecular Biology (Clifton, N.J.)|March 5, 2013
Erythropoietin and engineered innate repair activatorsMichael Brines, Anthony CeramiPharmacology & Therapeutics|March 3, 2015
Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietinMassimo Collino, Christoph Thiemermann, Anthony Cerami, et al.FEMS Immunology and Medical Microbiology|March 18, 2011
The erythropoietin analogue ARA290 modulates the innate immune response and reduces Escherichia coli invasion into urothelial cellsKamila Polgárová, Petra Lüthje, Anthony Cerami, et al.The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|April 9, 2004
Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?Giovanni Grasso, Alessandra Sfacteria, Anthony Cerami, et al.Pain Reports|February 3, 2018
Targeting the innate repair receptor to treat neuropathyAlbert Dahan, Michael Brines, Marieke Niesters, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 29, 2002
Neuroprotective properties of epoetin alfaAnthony Cerami, Michael Brines, Pietro Ghezzi, et al.Pageof 7